7 terminated. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 7 |
| Phase 3 | 1 | Terminated 1 |
Follow Staphylococcal Infections: new trials by email Literature Review of Staphylococcal Infections trials Research Report on Staphylococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo J. lividum - Atopic Dermatitis | Phase 2 | Terminated | DermBiont, Inc. | 9 | 2019-05-20 | 2021-06-18 |
| Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome NDV-3A - Autosomal-dominant Hyper-IgE Syndrome | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 3 | 2016-11-17 | 2020-06-30 |
| Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus. ASN100, Placebo - Pneumonia, Ventilator-associated, Pneumonia, Staphylococcal | Phase 2 | Terminated | Arsanis, Inc. | 155 | 2016-11-01 | 2019-07-31 |
| Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine, Placebo - Staphylococcal Vaccine | Phase 2 | Terminated | Pfizer | 3450 | 2015-07-02 | 2021-01-05 |
| Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults rifabutin plus trimethoprim sulfamethoxazole, placebo plus trimethoprim-sulfamethoxazole - Staphylococcus Aureus, HIV Infections | Phase 2 | Terminated | University of California, San Francisco | 12 | 2009-07-01 | 2014-05-14 |
| Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia daptomycin, vancomycin - Endocarditis, Bacterial, Infective Endocarditis | Phase 2 | Terminated | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 38 | 2008-09-17 | 2018-12-24 |
| Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) V710, Placebo - Staphylococcus Aureus, Bacteremia | Phase 2 / Phase 3 | Terminated | Merck Sharp & Dohme LLC | 8031 | 2007-12-01 | 2015-10-02 |
Bacteremia (2) · Dermatitis, Atopic (1) · Endocarditis (1) · Endocarditis, Bacterial (1) · Gram-Positive Bacterial Infections (1) · HIV Infections (1) · Job Syndrome (1) · Mediastinitis (1) · Pneumonia (1) · Pneumonia, Staphylococcal (1) · Pneumonia, Ventilator-Associated (1)
Bacterial Infections (7) · Bacterial Infections and Mycoses (7) · Infections (7) · Gram-Positive Bacterial Infections (6) · Immune System Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Immunologic Deficiency Syndromes (2) · Inflammation (2) · Respiratory Tract Diseases (2) · Sepsis (2) · Systemic Inflammatory Response Syndrome (2) · Blood-Borne Infections (1)
ASN100 (1) · Daptomycin (1) · Injections (1) · Rifabutin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · V710 vaccine (1) · Vaccines (1) · Vancomycin (1)
Arsanis, Inc. (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · DermBiont, Inc. (1) · Merck Sharp & Dohme LLC (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Pfizer (1) · University of California, San Francisco (1)
United States (5) · Austria (2) · France (2) · Hungary (2) · Spain (2) · Bulgaria (1) · Canada (1) · Czechia (1) · Dominican Republic (1) · Georgia (1) · Germany (1) · India (1) · Israel (1) · Japan (1) · Poland (1)
Alexandra Freeman, M.D. (1) · Brian S Schwartz, MD (1) · Daisy Blanco, MD (1) · Henry F Chambers, MD (1) · Peter Pertel, MD (1)
2014 (1), 2016 (1)